Studies in rats have demonstrated that elevated CYP1B1 activity is linked to pathological conditions such as cardiac hypertrophy, vasoconstriction, endothelial dysfunction, and increased ROS production (Jennings et al., 2010; Jennings et al., 2014). The gene discussed is CYP1B1; the disease is endothelial dysfunction.